1103 Results for "

Bioavailability

" in MedChemExpress (MCE) Product Catalog:
Products (1103)

1103 Results for "Bioavailability" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-111790
CAS No.: 2285330-15-4
Purity:  ≥98.0%
Target:  

Proteasome Apoptosis

Research Areas:  

Cancer

M3258 is an orally bioavailable, potent, reversible and highly selective immunoproteasome subunit LMP7 (β5i) inhibitor. M3258 exerts high biochemical (IC50=3.6 nM) and cellular (IC50=3.4 nM) potency against the LMP7 subunit. M3258 shows strong antitumor efficacy in multiple myeloma xenograft models. M3258 leads to a significant and prolonged suppression of tumor LMP7 activity and ubiquitinated protein turnover and the induction of apoptosis in multiple myeloma cells .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-12113
CAS No.: 935888-69-0
Purity:  99.76%
Synonyms: ONX 0912; PR-047
Research Areas:  

Cancer

Oprozomib (PR-047) is an orally bioavailable and selective peptide epoxyketone proteasome inhibitor with IC50s of 36 and 82 nM for proteasome (β5) and immunoproteasome (LMP7), respectively. Oprozomib (ONX 0912) induces apoptosis in MM cells .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-100026
CAS No.: 1927857-56-4
Purity:  98.01%
Target:  

mTOR

Research Areas:  

Cancer

PQR620 is an orally bioavailable and selective brain penetrant inhibitor of mTORC1/2 .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-125824
CAS No.: 2230198-02-2
Purity:  99.85%
Synonyms: PF-06882961
Target:  

GCGR

Research Areas:  

Metabolic Disease

Danuglipron (PF-06882961) is an orally active glucagon-like peptide-1 receptor (GLP-1R) agonist. Danuglipron has the potential for type 2 diabetes research .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-111505
CAS No.: 2089293-61-6
Purity:  99.65%
Research Areas:  

Cancer

NAcM-OPT is an orally bioavailable cullin neddylation 1 (DCN1) inhibitor, which potently inhibits the DCN1-UBE2M interaction .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-107981
CAS No.: 1941211-99-9
Purity:  98.36%
Target:  

Antifolate

Research Areas:  

Cancer

LSN 3213128 is a selective, nonclassical, orally bioavailable antifolate with potent and specific inhibitory activity for aminoimidazole-4-carboxamide ribonucleotide formyltransferase (AICARFT) with IC50 of 16 nM. LSN 3213128 exhibits anti-tumor activity .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-114177
CAS No.: 2185857-97-8
Purity:  99.91%
Synonyms: PF-06873600
Target:  

CDK

Research Areas:  

Cancer

PF-06873600 is a selective and orally bioavailable inhibitor of cyclin-dependent kinase (CDK), with Ki values of 0.09 nM, 0.13 nM and 0.16 nM for CDK2, CDK4 and CDK6, respectively. PF-06873600 has potential antineoplastic activity .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-15419
CAS No.: 199864-86-3
Purity:  99.78%
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

RS-127445 hydrochloride is a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist with a pKi of 9.5. RS-127445 hydrochloride shows 1000 fold selectivity for this receptor as compared to numerous other receptor and ion channel binding sites .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-15419A
CAS No.: 199864-87-4
Purity:  99.62%
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

RS-127445 is a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist with a pKi of 9.5. RS-127445 shows 1000 fold selectivity for this receptor as compared to numerous other receptor and ion channel binding sites .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-13491
CAS No.: 1033769-28-6
Purity:  99.44%
Target:  

Trk Receptor

Research Areas:  

Cancer

GNF-5837 is a potent, selective, and orally bioavailable pan-tropomyosin receptor kinase (TRK) inhibitor which display antiproliferative effects in cellular Ba/F3 assays ( IC50 values of 7 nM, 9 nM and 11 nM for cells containing the fusion proteins Tel-TrkC, Tel-TrkB and Tel-TrkA, respectively) .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-124634
CAS No.: 2170608-82-7
Purity:  99.68%
Target:  

PANK

Research Areas:  

Neurological Disease

PZ-2891 is an orally bioavailable, brain penetrant pantothenate kinase (PANK) modulator. PZ-2891 act as an orthosteric inhibitor at high concentrations and an allosteric activator at lower sub-saturating concentrations. PZ-2891 inhibits human pantothenate kinases PANK1β, PANK2, and PANK3 with IC50s of 40.2 nM, 0.7 nM and 1.3 nM, respectively .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-13265
CAS No.: 935881-37-1
Purity:  98.52%
Synonyms: HDAC-42; OSU-HDAC42
Target:  

HDAC Autophagy Apoptosis

Research Areas:  

Cancer

AR-42 (HDAC-42; OSU-HDAC42) is a potent, orally bioavailable pan-HDAC inhibitor (IC50=16 nM). AR-42 induces growth inhibition, cell-cycle arrest, apoptosis, and activation of caspases-3/7. AR-42 promotes hyperacetylation of H3, H4, and alpha-tubulin, and up-regulation of p21. AR-42 shows cytotoxicity against various human cancer cell lines .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-102074
CAS No.: 1374006-96-8
Purity:  99.90%
Target:  

Measles Virus

Research Areas:  

Infection

ERDRP-0519, an orally bioavailable small-molecule Measles virus (MeV) polymerase inhibitor, prevents measles disease in squirrel monkeys (Saimiri sciureus). ERDRP-0519 inhibits morbilliviruses with nanomolar potency. .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-19883
CAS No.: 1110766-97-6
Synonyms: S-888711
Research Areas:  

Inflammation/Immunology

Lusutrombopag is an orally bioavailable thrombopoietin (TPO) receptor agonist, used for treatment of chronic liver disease.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-50911
CAS No.: 629664-81-9
Synonyms: FXR-450; XL335; WAY-362450
Target:  

FXR Autophagy

Research Areas:  

Metabolic Disease Cancer

Turofexorate isopropyl (FXR-450) is a potent, selective, and orally bioavailable FXR agonist with EC50 of 4 nM .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-111484
CAS No.: 1642297-01-5
Purity:  99.98%
Synonyms: SRN-927
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

GDC-0927 (SRN-927) is a potent, non-steroidal, orally bioavailable, selective estrogen receptor antagonist .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-12045
CAS No.: 173529-46-9
Purity:  99.94%
Synonyms: IVX-214
Research Areas:  

Cancer

HMN-214, an orally bioavailable proagent of HMN-176, is an inhibitor of polo-like kinase-1 (plk1), with antitumor activity.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-124600
CAS No.: 1445790-55-5
Purity:  99.88%
Target:  

HBV

Research Areas:  

Infection

NVR 3-778 is a first-in-Class and oral bioavailable HBV CAM (capsid assembly modulator) belonging to the SBA (sulfamoylbenzamide) class, with anti-HBV activity .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-103088
CAS No.: 1369489-71-3
Purity:  99.57%
Synonyms: E7046
Research Areas:  

Endocrinology Cancer

Palupiprant (E7046) is an orally bioavailable and specific EP4 antagonist, with IC50 of 13.5 nM and Ki of 23.14 nM. Palupiprant exhibits anti-tumor activities .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-111498A
CAS No.: 610318-54-2
Purity:  99.76%
Synonyms: Abequolixron
Target:  

LXR

Research Areas:  

Inflammation/Immunology Cancer

RGX-104 is an orally bioavailable and potent liver-X nuclear hormone receptor (LXR) agonist that modulates innate immunity via transcriptional activation of the ApoE gene.
loading...
    loading...